Heritage Cannabis (CSE: CANN- OTCQX: HERTF) CEO Clint Sharples joined Steve Darling from Proactive to share details the company has announced the company will be launching several new medical products formulated with the patented VESIsorb delivery system technology in the U.S.
Sharples telling Proactive the first product, through their subsidiary Opticann, will be ArthroCBD soft gel capsules which are expected to be launched on April 19th.
Sharples also said the company has also signed an expansion of its supply and distribution agreement with Geocann for the Canadian marketplace.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis Holdings Corp. named herein, including the promotion by the Company of Heritage Cannabis Holdings Corp. in any Content on the...
FOR OUR FULL DISCLAIMER CLICK HERE